Results 31 to 40 of about 1,043 (179)
Enhanced External Counterpulsation for Management of Postacute Sequelae of SARS-CoV-2 Associated Microvascular Angina and Fatigue: An Interventional Pilot Study. [PDF]
Cardiol Res Pract, 2023 Background. Postacute sequelae of SARS‐CoV‐2 infection (PASC) are a novel clinical syndrome characterized in part by endothelial dysfunction. Enhanced external counterpulsation (EECP) produces pulsatile shear stress, which has been associated with improvements in systemic endothelial function. Objective. To explore the effects of EECP on symptom burden,
Wu E +7 more
europepmc +2 more sources
Enhanced External Counterpulsation in Chronic Heart Failure: Where Do We Stand? [PDF]
Acta Medica Indonesiana, 2015 Heart failure has been known as an increasing health burden worldwide and the prevalence is expected to rise more than 23 million in 2030. Chronic heart failure has characteristic of ventricular dysfunction which will cause dyspnea, fatique, and finally ...
Ryan Ranitya
doaj +6 more sources
Enhanced external counterpulsation: A unique treatment for the "No-Option" refractory angina patient. [PDF]
J Clin Pharm Ther, 2021 A growing data pool suggests that EECP is safe, noninvasive, unique, and cost‐effective treatment strategy, providing relief of angina and improving the quality of life in the majority of patients treated. Abstract What is known and objectives Coronary artery disease (CAD) is the leading cause of death in the United States.
Caceres J, Atal P, Arora R, Yee D.
europepmc +2 more sources
Predictors of treatment benefits after enhanced external counterpulsation in patients with refractory angina pectoris. [PDF]
Clin Cardiol, 2021 Abstract Background Enhanced external counterpulsation (EECP) is a noninvasive treatment that can decrease limiting symptoms in patients with refractory angina pectoris (RAP). Identifying responders to EECP is important as EECP is not widely available and relatively time intensive.
Wu E +3 more
europepmc +2 more sources
An update on enhanced external counterpulsation [PDF]
Clinical Cardiology, 2005 The development of advanced revascularization techniques has resulted in the growth of a subset of patients with coronary artery disease who are nonrevascularizable and are considered to have refractory angina. Enhanced external counterpulsation (EECP) has been developed for the management of these patients with chronic, refractory disease.
Michael L, Shea +2 more
openaire +2 more sources
Application and research progress on enhanced external counterpulsation in cardiovascular rehabilitation [PDF]
Xin yixue, 2022 Enhanced external counterpulsation （EECP） is a non-invasive auxiliary circulatory technology and device, which plays a therapeutic role by synchronizing cardiac systolic and diastolic movement, improving hemodynamics, enhancing vascular endothelial ...
Liang Suzhen, Qian Xiaoxian
doaj +1 more source
Artificial Muscles and Soft Robotic Devices for Treatment of End‐Stage Heart Failure
Advanced Materials, Volume 35, Issue 19, May 11, 2023., 2023 This review discusses the present state and future direction of soft robotic biomedical devices in supporting the inotropic function of the heart, focusing on electrothermally artificial heart muscles. The current state of the ventricular assist devices and the key factors for the development of a full soft robotic ventricular assist device were ...
Alexander Weymann +9 more
wiley +1 more source
Method for estimating pulsatile wall shear stress from one‐dimensional velocity waveforms
Physiological Reports, Volume 11, Issue 7, April 2023., 2023 Abstract Wall shear stress (WSS)—a key regulator of endothelial function—is commonly estimated in vivo using simplified mathematical models based on Poiseuille's flow, assuming a quasi‐steady parabolic velocity distribution, despite evidence that more rapidly time‐varying, pulsatile blood flow during each cardiac cycle modulates flow‐mediated dilation (
J. C. Muskat +3 more
wiley +1 more source
Acta Physiologica, Volume 237, Issue 3, March 2023., 2023 Abstract Aims We aimed to investigate the tolerability, safety, and effectiveness of enhanced external counterpulsation therapy (EECP) versus individual shear rate therapy (ISRT) in patients with lower extremity atherosclerotic disease (LEAD). Methods Eighteen patients (age: 73.1 ± 6 years) underwent EECP and ISRT, each daily over five consecutive days
Nibras Soubh +4 more
wiley +1 more source
Table_1_Effects of Enhanced External Counterpulsation With Different Sequential Levels on Lower Extremity Hemodynamics.XLSX [PDF]
, 2021 Objective: This study aimed to investigate acute hemodynamics of lower extremities during enhanced external counterpulsation with a three-level sequence at the hips, thighs, and calves (EECP-3), two-level sequence at the hips and thighs (EECP-2), and ...
Chubin Zhong (11875730) +9 more
core +1 more source